NEOGEN Income Statement - TTM - Neogen Chemicals Limited

Income Statement (TTM)

Neogen Chemicals Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	3,231	3,260	3,364	3,445	3,757	4,231	4,872	5,505	5,855	6,391	6,862	7,032	7,168	6,949	6,907	7,057	7,374	7,744	7,776	7,843
Change (%)		0.89	3.19	2.39	9.07	12.63	15.15	12.98	6.35	9.16	7.37	2.47	1.93	-3.04	-0.61	2.18	4.48	5.02	0.41	0.87
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	1,940	1,949	1,976	1,967	2,129	2,372	2,750	3,102	3,248	3,565	3,940	3,987	4,074	3,926	3,876	3,870	4,144	4,327	4,289	4,284
Change (%)		0.45	1.39	-0.45	8.23	11.39	15.93	12.79	4.74	9.75	10.52	1.18	2.19	-3.62	-1.28	-0.15	7.07	4.43	-0.88	-0.12
% of Revenue	60.05	59.79	58.75	57.12	56.68	56.05	56.43	56.34	55.49	55.79	57.42	56.70	56.84	56.50	56.12	54.84	56.20	55.88	55.16	54.62

Gross Operating Profit	1,291	1,311	1,388	1,477	1,628	1,860	2,123	2,404	2,606	2,826	2,922	3,045	3,094	3,023	3,031	3,187	3,230	3,416	3,486	3,559
Change (%)		1.56	5.86	6.44	10.18	14.26	14.15	13.23	8.42	8.42	3.40	4.22	1.60	-2.28	0.25	5.16	1.35	5.77	2.04	2.09
% of Revenue	39.95	40.21	41.25	42.88	43.32	43.95	43.57	43.66	44.51	44.21	42.58	43.30	43.16	43.50	43.88	45.16	43.80	44.12	44.84	45.38

SG&A	216	221	209	215	250	281	334	353	410	448	500	499	617	662	660	651	663	653	686	684
Change (%)		2.45	-5.61	3.01	16.24	12.66	18.73	5.60	16.10	9.42	11.47	-0.18	23.64	7.28	-0.24	-1.35	1.87	-1.57	5.07	-0.28
% of Revenue	6.68	6.78	6.20	6.24	6.65	6.65	6.86	6.41	7.00	7.01	7.28	7.09	8.60	9.52	9.55	9.22	8.99	8.43	8.82	8.72

R&D
Change (%)
% of Revenue

OpEx	2,687	2,711	2,790	2,852	3,120	3,544	4,124	4,686	5,014	5,491	5,908	6,059	6,198	6,094	6,035	6,172	6,416	6,656	6,690	6,741
Change (%)		0.91	2.88	2.24	9.39	13.61	16.35	13.65	6.99	9.51	7.59	2.57	2.28	-1.67	-0.97	2.26	3.95	3.74	0.52	0.75
% of Revenue	83.15	83.16	82.92	82.79	83.04	83.76	84.63	85.13	85.64	85.92	86.09	86.17	86.47	87.69	87.38	87.45	87.00	85.95	86.04	85.94

Operating Income	544	549	575	593	637	687	749	819	840	900	954	972	970	856	872	886	958	1,088	1,085	1,103
Change (%)		0.81	4.68	3.15	7.50	7.86	8.98	9.32	2.65	7.02	6.08	1.91	-0.25	-11.80	1.91	1.62	8.18	13.56	-0.28	1.60
% of Revenue	16.85	16.84	17.08	17.21	16.96	16.24	15.37	14.87	14.36	14.08	13.91	13.83	13.53	12.31	12.62	12.55	13.00	14.05	13.96	14.06

Interest Expense	-121	-122	-129	-141	-136	-168	-178	-216	-230	-233	-237	-336	-326	-365	-378	-411	-385	-414	-379	-514
Change (%)		0.39	6.01	8.82	-3.18	23.44	5.85	21.07	6.96	1.26	1.54	41.81	-3.01	11.87	3.59	8.84	-6.37	7.56	-8.57	35.63
% of Revenue	-3.76	-3.74	-3.84	-4.08	-3.63	-3.97	-3.65	-3.91	-3.94	-3.65	-3.45	-4.78	-4.55	-5.25	-5.47	-5.83	-5.22	-5.35	-4.87	-6.55

Net Income	290	293	313	326	364	383	446	484	471	513	500	486	467	330	356	374	404	494	348	336
Change (%)		1.11	6.87	3.96	11.64	5.37	16.49	8.38	-2.69	8.97	-2.57	-2.70	-4.01	-29.21	7.90	4.82	8.08	22.18	-29.42	-3.47
% of Revenue	8.97	8.99	9.31	9.46	9.68	9.05	9.16	8.79	8.04	8.03	7.28	6.91	6.51	4.75	5.16	5.30	5.48	6.37	4.48	4.29

Source: Capital IQ

Neogen Chemicals Limited - Income Statement (TTM)

Income Statement (TTM)

Other Listings